Suchergebnisse - "Evans, T. R."

PubPharm (323)

1

A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Sacco, J. | Jackson, R. | Corrie, P. | +18

2

A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08)

enthalten in: The oncologist | 2021

von McNamara, M. | Bridgewater, J. | Palmer, D. | +9

CommentIn: Oncologist. 2021 May;26(5):e902. - PMID 33539601

3

A Phase Ib Study of NUC‐1031 in Combination with Cisplatin for the First‐Line Treatment of Patients with Advanced Biliary Tract Cancer ( ABC‐08)

enthalten in: The oncologist | 2021

von McNamara, M. | Bridgewater, J. | Palmer, D. | +9

4

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer : A First-in-Human, Multicenter, Open-Label, Phase I Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Sarker, D. | Plummer, R. | Meyer, T. | +33

5

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

enthalten in: Journal for immunotherapy of cancer | 2020

von Cebon, J. | Gore, M. | Thompson, J. | +30

6

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Jones, R. | Ratain, M. | O'Dwyer, P. | +27

7

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine

enthalten in: British journal of cancer | 2019

von Twelves, C. | Anthoney, A. | Savulsky, C. | +9

8

Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours

enthalten in: British journal of cancer | 2019

von Evans, T. | Dean, E. | Molife, L. | +11

9

CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype

enthalten in: Cell reports | 2018

von Candido, J. | Morton, J. | Bailey, P. | +22

10

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma : A Phase III, Multicenter, Randomized Trial (SUMIT)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Carvajal, R. | Piperno-Neumann, S. | Kapiteijn, E. | +24

ErratumIn: J Clin Oncol. 2018 Dec 10;36(35):3528. - PMID 30523765

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]